Tilray expands medical cannabis portfolio in Australia

Tilray Brands has announced a significant expansion of its medical cannabis product offerings in the Australian market. This strategic move aims to broaden patient access to high-quality medical cannabis treatments across the country. The company is introducing a diverse range of new products, catering to various therapeutic needs and patient preferences. This expansion reinforces Tilray's commitment to serving the growing Australian medical cannabis sector and solidifies its position as a key player in the global pharmaceutical cannabis industry.